ChemoCentryx Competitors and Similar CompaniesClear all

ChemoCentryx's competitors and similar companies include Agios Pharmaceuticals and Pharmstandard.

	ChemoCentryx ChemoCentryx is a biopharmaceutical company commercializing and developing medications for inflammatory and autoimmune diseases and cancer.	Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.	Pharmstandard Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.
Founding Date	Founding Date 1997	Founding Date 2008	Founding Date 2003
Type	Type Subsidiary	Type Public	Type Subsidiary
Tags	Tags Healthcare drug development oncology pharma	Tags Healthcare drug development oncology pharma	Tags Healthcare drug development pharma
Locations	Locations San Carlos, US HQ	Locations Cambridge, US HQ	Locations Dolgoprudny, RU HQ Kursk, RU Moscow, RU Petrovo Dalnee, RU Tomsk, RU Ufa, RU Vol'ginskii, RU
Employees	Employees 51	Employees 53611% increase	Employees 1,77814% increase
Financial
Revenue (est.)	Revenue (est.) $32.2m (FY, 2021)	Revenue (est.) $54m (FY, 2025)	Revenue (est.) ₽152.1b (FY, 2024)
Cost of goods	Cost of goods $302k (FY, 2021)	Cost of goods $6.3m (FY, 2025)	Cost of goods ₽117b (FY, 2024)
Gross profit	Gross profit $31.9m (FY, 2021)	Gross profit $47.7m (FY, 2025)	Gross profit ₽35.2b (FY, 2024)
Net income	Net income ($131.8m) (FY, 2021)	Net income ($412.8m) (FY, 2025)	Net income ₽22.7b (FY, 2024)

For sources of this data, please see the company profile

Cambridge, US

Employees

536↑ 11% increase

Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.

Dolgoprudny, RU

Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.

Financial